TY - JOUR
T1 - Oxidative stress, anti-oxidants and the cross-sectional and longitudinal association with depressive symptoms
T2 - Results from the CARDIA study
AU - Black, C. N.
AU - Penninx, B. W.J.H.
AU - Bot, M.
AU - Odegaard, A. O.
AU - Gross, M. D.
AU - Matthews, K. A.
AU - Jacobs, D. R.
N1 - Publisher Copyright:
© 2016, Nature Publishing Group. All rights reserved.
PY - 2016
Y1 - 2016
N2 - Depression may be accompanied by increased oxidative stress and decreased circulating anti-oxidants. This study examines the association between depressive symptoms, F2-isoprostanes and carotenoids in a US community sample. The study includes 3009 participants (mean age 40.3, 54.2% female) from CARDIA (Coronary Artery Risk Development in Young Adults). Cross-sectional analyses were performed on data from the year 15 examination (2000–2001) including subjects whose depressive symptoms were assessed with the Center for Epidemiologic Studies Depression Scale (CES-D) and had measurements of plasma F2-isoprostanes (gas chromatography/mass spectrometry) or serum carotenoids (high-performance liquid chromatography). Carotenoids zeaxanthin/lutein, β-cryptoxanthin, lycopene, α-carotene, β-carotene were standardized and summed. Longitudinal analyses were conducted using the data from other examinations at 5-year intervals. Cross-lagged analyses investigated whether CES-D predicted F2-isoprostanes or carotenoids at the following exam, and vice versa. Regression analyses were controlled for sociodemographics, health and lifestyle factors. F2-isoprostanes were higher in subjects with depressive symptoms (CES-D ≥ 16) after adjustment for sociodemographics (55.7 vs 52.0 pg ml−1; Cohen’s d = 0.14, P<0.001). There was no difference in F2-isoprostanes after further adjustment for health and lifestyle factors. Carotenoids were lower in those with CES-D scores ≥ 16, even after adjustment for health and lifestyle factors (standardized sum 238.7 vs 244.0, Cohen’s d = − 0.16, P<0.001). Longitudinal analyses confirmed that depression predicts subsequent F2-isoprostane and carotenoid levels. Neither F2-isoprostanes nor carotenoids predicted subsequent depression. In conclusion, depressive symptoms were cross-sectionally and longitudinally associated with increased F2-isoprostanes and decreased carotenoids. The association with F2-isoprostanes can largely be explained by lifestyle factors, but lower carotenoids were independently associated with depressive symptoms.
AB - Depression may be accompanied by increased oxidative stress and decreased circulating anti-oxidants. This study examines the association between depressive symptoms, F2-isoprostanes and carotenoids in a US community sample. The study includes 3009 participants (mean age 40.3, 54.2% female) from CARDIA (Coronary Artery Risk Development in Young Adults). Cross-sectional analyses were performed on data from the year 15 examination (2000–2001) including subjects whose depressive symptoms were assessed with the Center for Epidemiologic Studies Depression Scale (CES-D) and had measurements of plasma F2-isoprostanes (gas chromatography/mass spectrometry) or serum carotenoids (high-performance liquid chromatography). Carotenoids zeaxanthin/lutein, β-cryptoxanthin, lycopene, α-carotene, β-carotene were standardized and summed. Longitudinal analyses were conducted using the data from other examinations at 5-year intervals. Cross-lagged analyses investigated whether CES-D predicted F2-isoprostanes or carotenoids at the following exam, and vice versa. Regression analyses were controlled for sociodemographics, health and lifestyle factors. F2-isoprostanes were higher in subjects with depressive symptoms (CES-D ≥ 16) after adjustment for sociodemographics (55.7 vs 52.0 pg ml−1; Cohen’s d = 0.14, P<0.001). There was no difference in F2-isoprostanes after further adjustment for health and lifestyle factors. Carotenoids were lower in those with CES-D scores ≥ 16, even after adjustment for health and lifestyle factors (standardized sum 238.7 vs 244.0, Cohen’s d = − 0.16, P<0.001). Longitudinal analyses confirmed that depression predicts subsequent F2-isoprostane and carotenoid levels. Neither F2-isoprostanes nor carotenoids predicted subsequent depression. In conclusion, depressive symptoms were cross-sectionally and longitudinally associated with increased F2-isoprostanes and decreased carotenoids. The association with F2-isoprostanes can largely be explained by lifestyle factors, but lower carotenoids were independently associated with depressive symptoms.
UR - http://www.scopus.com/inward/record.url?scp=84979896709&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84979896709&partnerID=8YFLogxK
U2 - 10.1038/tp.2016.5
DO - 10.1038/tp.2016.5
M3 - Article
C2 - 26905415
AN - SCOPUS:84979896709
SN - 2158-3188
VL - 6
JO - Translational psychiatry
JF - Translational psychiatry
IS - 2
M1 - e743
ER -